Search the Newsreel

Q4 EPS Forecast for Hallador Energy Lowered by Analyst

Handelsbanken Fonder AB Grows Stake in Halozyme Therapeutics, Inc. $HALO

Handelsbanken Fonder AB significantly increased its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 28.1% in Q2 2026, now holding 631,899 shares valued at $49.5 million. This move is part of broader institutional investment, with various firms adjusting their holdings, and insiders also making transactions. …

Hindustan Aeronautics Q1 results: HAL profit rises 15% YoY to ₹1,581 crore, revenue climbs 14%; check key numbers

Assenagon Asset Management S.A. Makes New $7.73 Million Investment in Robert Half Inc. $RHI

Assenagon Asset Management S.A. has initiated a new $7.73 million investment in Robert Half Inc. (NYSE:RHI) by acquiring 251,702 shares, representing a 0.25% stake in the company. This move comes as other institutional investors have also adjusted their positions in Robert Half, which currently …

Assenagon Asset Management S.A. Trims Stake in Halliburton Company $HAL

Assenagon Asset Management S.A. significantly reduced its holdings in Halliburton Company (NYSE:HAL) by 90.2% in the second quarter, selling over 2 million shares. Despite this, institutional investors still hold a substantial 85.23% of the company, and analysts maintain a "Moderate Buy" consensus rating with …

Vishal Mega Mart Shares Fall 2.11%, Trading at Rs 107.92

Halozyme Therapeutics, Inc. (HALO) stock price, news, quote and history

Challenger Gold Director Boosts Equity Stake Through Fee-For-Shares Arrangement

Mahalaxmi Rubtech standalone net profit rises 29.95% in the June 2026 quarter

Hallador Energy Co (HNRG) investor Becker reports 3.0% stake in Schedule 13G/A

Mark D. Becker, a Hallador Energy Co (HNRG) shareholder, has filed an amended ownership report (Schedule 13G/A) indicating a beneficial ownership of 1,437,573 shares, which constitutes 3.0% of the company's common stock. These shares are held across two trusts, The MDB Irrevocable Trust and …

Hallador Energy (HNRG) Stock Faces Margin Squeeze As Merom Costs Bite

Hallador Energy (HNRG) reported a Q2 net loss of US$15.2 million, primarily due to high maintenance and purchased power costs at its Merom plant, leading to negative adjusted EBITDA. While the company is making progress on its Turtle Creek gas peaker project and has …

Halozyme director Connaughton sells $167,152 in shares

Halozyme Therapeutics director Bernadette Connaughton sold 1,626 shares of company stock for a total of $167,152 on August 10, 2026, at a price of $102.8 per share. This sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted in May 2025. Following the …

Halozyme Therapeutics (HALO) director sells 1,626 shares in Rule 10b5-1 plan trade

Halozyme Therapeutics (HALO) director Bernadette Connaughton sold 1,626 shares of common stock at $102.80 per share on August 10, 2026, under a Rule 10b5-1 trading plan adopted in May 2025. Following this transaction, she directly holds 40,418 shares. The sale, valued at approximately $167,000, …

Halozyme Therapeutics (HALO) affiliate plans stock option-related share sales in Form 144

Halozyme Therapeutics (HALO) filed a Form 144, indicating an affiliate's intention to sell common stock through Morgan Stanley Smith Barney LLC. These planned sales are linked to stock option exercises set for August 11, 2026, involving transactions for 32,659, 5,277, and 3,766 shares of …

Mahalaxmi Rubtech net profit rises 30% in Q1FY27 on revenue growth

Haleon plc (HLN) files Form 6-K on cash tender offer for 2027 3.375% notes

Haleon plc has filed a Form 6-K announcing a cash tender offer for its outstanding 2027 3.375% Fixed Rate Notes, as detailed in an exhibit dated August 11, 2026. This filing serves to inform U.S. investors about the debt-related transaction. The offer targets debt …

Risks From Edge Early Learning Relatively Contained for Charter Hall Social Infrastructure

Eshallgo Inc. Class A (EHGO) Live Share Price, Invest From India

This article provides a detailed financial overview of Eshallgo Inc. Class A (EHGO), including its live share price, performance metrics, historical returns, and fundamental indicators. It also presents quarterly and annual profit & loss statements, cash flow data, institutional holdings, and an overview of …

Hallador Energy (NASDAQ:HNRG) Shares Gap Down on Disappointing Earnings

Haleon unit launches tender offer for $2 billion 2027 notes

Haleon US Capital LLC, a wholly owned subsidiary of Haleon plc, has launched a tender offer to purchase all outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. This tender offer is part of Haleon's strategy to manage and optimize its debt portfolio, …

Haleon offers to buy back $2B of 3.375% notes due 2027 to optimize debt portfolio.

Haleon plc's subsidiary, Haleon US Capital LLC, has launched a tender offer to repurchase up to $1.999 billion of its 3.375% senior notes due in March 2027. This strategic move aims to optimize the company's debt portfolio and enhance financial flexibility, contingent on the …

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes …

REG - Haleon PLC Haleon US Capital - Cash tender offer - outstanding 2027 3.375% Notes

Haleon plc announced that its subsidiary, Haleon US Capital LLC, is initiating a cash tender offer to buy back all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. This move aligns with Haleon's capital allocation strategy and aims to optimize …

Technical Reactions to JMSB Trends in Macro Strategies

This article analyzes John Marshall Bancorp Inc. (NASDAQ: JMSB) using AI models to provide trading strategies. It identifies a weak near-term sentiment but strong mid and long-term outlooks, detailing risk-reward short setups and multi-timeframe signal analysis. Three distinct trading strategies—Position, Momentum Breakout, and Risk …

Cheap with attractive yield: Fair Value lifted for retail REIT after earnings

Deutsche Bank Aktiengesellschaft Reiterates Buy Rating for Marshalls (LON:MSLH)

Marshalls' (MSLH) "Buy" Rating Reaffirmed at Berenberg Bank

HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance

HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) announced better-than-expected revenue in Q2 CY2026, with sales up 47.7% year on year to $481 million. The company's full-year revenue guidance of $1.87 billion at …

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Rating of "Moderate Buy" by Analysts

Halozyme Therapeutics (NASDAQ:HALO) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $91.20, though some targets have been raised to $115. The company exceeded quarterly expectations with $2.28 EPS and $481 million in revenue, leading to positive …

Hallador Energy Co (HNRG) (Q2 2026) Earnings Call Highlights: Strategic Gas Project Advances ...

Hallador Energy (HNRG) reported a net loss of $15.2 million and negative adjusted EBITDA in Q2 2026, a significant decline from the prior year. Despite the financial setbacks, the company is progressing with its Turtle Creek natural gas project, reducing cost estimates to under …

Charter Hall Social Infrastructure REIT Affirms Edge Early Learning Lease Details and Maintains FY27 Forecast

Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia

A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and …

What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation

Halozyme Therapeutics (HALO) recently reported strong Q2 earnings, with revenue of US$481 million and net income of US$229.91 million, leading to raised full-year revenue guidance and new collaboration agreements. Despite a significant 1-year share price return of 63.17%, the company faces mixed valuation signals, …

(HLN) Risk Channels and Responsive Allocation

This article analyzes Haleon Plc (NYSE: HLN), identifying a strong near-term sentiment that could influence a neutral mid and long-term outlook. It highlights a significant 25.0:1 risk-reward setup, targeting a 7.7% gain against a 0.3% risk. The analysis also provides institutional trading strategies, including …

Charter Hall Social Infrastructure REIT Reaffirms FY27 Outlook Amid Edge Early Learning Update

Haleon plc (LON:HLN) Receives Average Recommendation of "Hold" from Analysts

Haleon plc (LON:HLN) has received an average "Hold" recommendation from six analysts, with three suggesting a "buy", two a "sell", and one a "hold". The average 12-month price target for the stock is GBX 395.67, with individual targets ranging from GBX 315 to GBX …